<p>A, dose-dependent effects of bortezomib-induced autophagy. HCC cells were treated with bortezomib at the indicated concentrations for 24 hours. Cell lysates were prepared for immunoblotting of microtubule-associated protein 1 light chain 3 (LC3). B, time-dependent effects of bortezomib-induced autophagy. Cells were exposed to bortezomib at the indicated concentrations for 24 or 48 hours. C, effects of bortezomib on LC3-II. <i>Left,</i> analysis of LC3-II staining by flow cytometry. Cells were treated with bortezomib at 800 nM for 16 or 24 hours. <i>Right,</i> analysis of LC3-II immunofluorescence. Hep3B cells were treated with bortezomib at 800 nM for 24 hours. D, <i>top,</i> LC3-GFP staining. <i>Bottom,</i> acridine orange stain.</p
<p><b>A.</b> Optical (<i>a</i> and <i>b</i> photomicrographs) and Scanning Electron Microscopy (<i>c...
Objective To investigate the effects of bortezomib on human osteosarcoma cells from the HOS cell lin...
<p><b>A</b>) Dose-response curve of SCCHN cell lines to MK-2206 and SAR245408. Cells were treated wi...
<p>A, dose-dependent analysis of CIP2A, Akt and 4EBP1 in HCC cells. Cells were exposed to bortezomib...
<p>A, <i>left,</i> chemical structures of bortezomib and ΔBtz. <i>Middle,</i> effects of bortezomib ...
<p>HEK293T cells were treated with different concentrations of bortezomib and the levels of autophag...
<p>(A) BC3 and BCBL1 cells were treated with bortezomib (20 nM for 16 hrs) with or without pre-treat...
<p>(A) Bortezomib-induced proteasome inhibition. Proteasome activity was measured by fluorogenic ass...
<p>A) Relative gene expression and B) western blot analysis of whole cell lysates for the expression...
<p>(A) Electron microscopy (EM) on BC3 and BCBL1 cells treated with 20 nM of bortezomib after 16 hrs...
<p>(A) Annexin V-APC/ PI double staining flow cytometry of each group treated with increasing concen...
<p>(A) Viability assay evaluated by trypan blue exclusion was performed in BC3 (left panel) and BCBL...
Although the introduction of bortezomib as a therapeutic strategy has improved the overall survival ...
Although the introduction of bortezomib as a therapeutic strategy has improved the overall survival ...
<p>A, ectopic expression of CIP2A-myc abolishes effects of bortezomib on autophagy in Huh-7 and Hep3...
<p><b>A.</b> Optical (<i>a</i> and <i>b</i> photomicrographs) and Scanning Electron Microscopy (<i>c...
Objective To investigate the effects of bortezomib on human osteosarcoma cells from the HOS cell lin...
<p><b>A</b>) Dose-response curve of SCCHN cell lines to MK-2206 and SAR245408. Cells were treated wi...
<p>A, dose-dependent analysis of CIP2A, Akt and 4EBP1 in HCC cells. Cells were exposed to bortezomib...
<p>A, <i>left,</i> chemical structures of bortezomib and ΔBtz. <i>Middle,</i> effects of bortezomib ...
<p>HEK293T cells were treated with different concentrations of bortezomib and the levels of autophag...
<p>(A) BC3 and BCBL1 cells were treated with bortezomib (20 nM for 16 hrs) with or without pre-treat...
<p>(A) Bortezomib-induced proteasome inhibition. Proteasome activity was measured by fluorogenic ass...
<p>A) Relative gene expression and B) western blot analysis of whole cell lysates for the expression...
<p>(A) Electron microscopy (EM) on BC3 and BCBL1 cells treated with 20 nM of bortezomib after 16 hrs...
<p>(A) Annexin V-APC/ PI double staining flow cytometry of each group treated with increasing concen...
<p>(A) Viability assay evaluated by trypan blue exclusion was performed in BC3 (left panel) and BCBL...
Although the introduction of bortezomib as a therapeutic strategy has improved the overall survival ...
Although the introduction of bortezomib as a therapeutic strategy has improved the overall survival ...
<p>A, ectopic expression of CIP2A-myc abolishes effects of bortezomib on autophagy in Huh-7 and Hep3...
<p><b>A.</b> Optical (<i>a</i> and <i>b</i> photomicrographs) and Scanning Electron Microscopy (<i>c...
Objective To investigate the effects of bortezomib on human osteosarcoma cells from the HOS cell lin...
<p><b>A</b>) Dose-response curve of SCCHN cell lines to MK-2206 and SAR245408. Cells were treated wi...